de Vere White R - Search Results

1

Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy.

Wilder RB, Hsiang JY, Ji M, Earle JD, de Vere White R. Wilder RB, et al. Among authors: de vere white r. Am J Clin Oncol. 2000 Apr;23(2):176-80. doi: 10.1097/00000421-200004000-00014. Am J Clin Oncol. 2000. PMID: 10776980 Clinical Trial.

2

Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy.

DeVere White RW, Meyers FJ, Soares SE, Miller DG, Soriano TF. DeVere White RW, et al. J Urol. 1992 Mar;147(3 Pt 2):947-51. doi: 10.1016/s0022-5347(17)37430-x. J Urol. 1992. PMID: 1371566

3

Human androgen receptor expression in prostate cancer following androgen ablation.

de Vere White R, Meyers F, Chi SG, Chamberlain S, Siders D, Lee F, Stewart S, Gumerlock PH. de Vere White R, et al. Eur Urol. 1997;31(1):1-6. doi: 10.1159/000474409. Eur Urol. 1997. PMID: 9032526

4

Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy.

Chou RH, Wilder RB, Ji M, Ryu JK, Leigh BR, Earle JD, Doggett RL, Kubo HD, Roach M, deVere White RW. Chou RH, et al. Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):115-9. doi: 10.1016/s0360-3016(00)00422-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 10758312

5

Effects of a mushroom mycelium extract on the treatment of prostate cancer.

deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. deVere White RW, et al. Urology. 2002 Oct;60(4):640-4. doi: 10.1016/s0090-4295(02)01856-3. Urology. 2002. PMID: 12385925 Clinical Trial.

6

BCL2 antisense reduces prostate cancer cell survival following irradiation.

Scott SL, Higdon R, Beckett L, Shi XB, deVere White RW, Earle JD, Gumerlock PH. Scott SL, et al. Cancer Biother Radiopharm. 2002 Dec;17(6):647-56. doi: 10.1089/108497802320970253. Cancer Biother Radiopharm. 2002. PMID: 12537668

7

Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.

deVere White RW, Hackman RM, Soares SE, Beckett LA, Li Y, Sun B. deVere White RW, et al. Urology. 2004 Feb;63(2):259-63. doi: 10.1016/j.urology.2003.09.061. Urology. 2004. PMID: 14972467 Clinical Trial.

8

Analysis of treatment for small cell cancer of the bladder and report of three cases.

Karpman E, Goldberg Z, Saffarian A, Gandour-Edwards R, Ellison LM, deVere White RW. Karpman E, et al. Urology. 2004 Sep;64(3):494-8. doi: 10.1016/j.urology.2004.04.038. Urology. 2004. PMID: 15351578 Review.

9

Cost-benefit and outcome analysis: effect of prostate biopsy undergrading.

Cambio AJ, Ellison LM, Chamie K, deVere White RW, Evans CP. Cambio AJ, et al. Urology. 2007 Jun;69(6):1152-6. doi: 10.1016/j.urology.2007.02.002. Urology. 2007. PMID: 17572205 Clinical Trial.

10

Current applications for prostate-specific antigen doubling time.

Ramírez ML, Nelson EC, Devere White RW, Lara PN Jr, Evans CP. Ramírez ML, et al. Eur Urol. 2008 Aug;54(2):291-300. doi: 10.1016/j.eururo.2008.04.003. Epub 2008 Apr 11. Eur Urol. 2008. PMID: 18439749 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters